Home/Filings/4/0001562180-25-002271
4//SEC Filing

Harr Steve 4

Accession 0001562180-25-002271

CIK 0001770121other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 8:12 PM ET

Size

16.3 KB

Accession

0001562180-25-002271

Insider Transaction Report

Form 4
Period: 2025-03-06
Harr Steve
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2025-03-10$2.56/sh12,820$32,8197,876,930 total
  • Award

    Restricted Stock Units

    2025-03-06+166,667166,667 total
    Common Stock (166,667 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-0750,000150,000 total
    Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-07+50,0007,889,750 total
  • Award

    Stock Option (Right to Buy)

    2025-03-06+750,000750,000 total
    Exercise: $2.55Exp: 2035-03-05Common Stock (750,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    167,000
  • Common Stock

    (indirect: By Trust)
    682,500
  • Common Stock

    (indirect: By Trust)
    167,000
Footnotes (5)
  • [F1]Brian L. Harr is the trustee of these trusts, whose sole beneficiaries are members of the reporting person's immediate family.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
  • [F3]The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
  • [F4]The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
  • [F5]The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through such date.

Issuer

Sana Biotechnology, Inc.

CIK 0001770121

Entity typeother

Related Parties

1
  • filerCIK 0001627387

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 8:12 PM ET
Size
16.3 KB